FDA.reportPublic FDA data

LAPATINIB Pharmacologic Class Indexing

Class set ID
e5179b5a-7e17-413b-90db-688cd6d174f7
Version
2
Effective date
20180813
Type
Indexing - Pharmacologic Class

Mapped DailyMed Labels#

Label, Manufacturer, Effective table
LabelManufacturerEffectiveSPL version
These highlights do not include all the information needed to use TYKERB safely and effectively. See full prescribing information for TYKERB. TYKERB ® (lapatinib) tablets, for oral use Initial U.S. Approval: 2007Novartis Pharmaceuticals Corporation2026012714
These highlights do not include all the information needed to use lapatinib tablets safely and effectively. See full prescribing information for lapatinib tablets. LAPATINIB tablets, for oral use Initial U.S. Approval: 2007Lupin Pharmaceuticals, Inc. | NATCO PHARMA LIMITED | Natco Pharma Limited-Pharma Division202506104
LAPATINIB tablets, for oral use These highlights do not include all the information needed to use LAPATINIB TABLETS safely and effectively. See full prescribing information for LAPATINIB TABLETS. Initial U.S. Approval: 2007AvKARE202503121
These highlights do not include all the information needed to use LAPATINIB TABLETS safely and effectively. See full prescribing information for LAPATINIB TABLETS. LAPATINIB tablets, for oral use Initial U.S. Approval: 2007Teva Pharmaceuticals, Inc.202311307